• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 21, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Fatality rates are high within 2 years of drug-induced liver injury

Bioengineer by Bioengineer
June 26, 2017
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Most patients suffering liver toxicity due to medications or herbal or dietary supplements recover from the acute liver injury without long-term problems, but some do not survive the injury or they require liver transplantation. In a recent study, nearly 10% of patients with definite, highly likely, or probable drug-induced liver injury had a fatal outcome within 2 years of onset.

In the 107 deaths among 1089 patients in the study, drug-induced liver injury was the primary cause of death in 68 patients and was a contributing cause in another 15 (at total of 7.6%). The remaining 22 patients had fatal outcomes unrelated to drug-induced liver injury.

The findings are published in Hepatology.

###

Media Contact

Penny Smith
[email protected]

http://newsroom.wiley.com/

http://dx.doi.org/10.1002/hep.29283

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Study reveals clonal diversity among CCR8-positive regulatory T cells in human cancer

August 21, 2026

Study explores hope among parents after infants leave neonatal intensive care

August 21, 2026

US Adults’ Progression from Preclinical to Clinical Obesity: Incidence and Risk Factors

August 21, 2026

China’s Hypertensive Patients Face Plan-Related Inequalities in Costs, Disease Progression and Mortality

August 21, 2026
Please login to join discussion

POPULAR NEWS

  • Study reveals clonal diversity among CCR8-positive regulatory T cells in human cancer

    29 shares
    Share 12 Tweet 7
  • Study explores hope among parents after infants leave neonatal intensive care

    29 shares
    Share 12 Tweet 7
  • US Adults’ Progression from Preclinical to Clinical Obesity: Incidence and Risk Factors

    29 shares
    Share 12 Tweet 7
  • Dual-gain color-NIR chip enables fluorescence-guided lung and breast cancer surgery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study reveals clonal diversity among CCR8-positive regulatory T cells in human cancer

Study explores hope among parents after infants leave neonatal intensive care

US Adults’ Progression from Preclinical to Clinical Obesity: Incidence and Risk Factors

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.